Study cohort at inception | Subjects with incident work-related lower respiratory symptoms | p Value* | Subjects with incident work-related symptoms of rhinoconjunctivitis | p Value* | ||
No (%) | No (%) | No (%) | ||||
Number | 298 | 13 | 19 | |||
Atopy | 104 (34.9) | 6 (46.2) | 0.38 | 8 (42.1) | 0.49 | |
Physician-diagnosed asthma | 56 (18.8) | 6 (46.2) | 0.01 | 2 (10.5) | 0.34 | |
BHR | 57 (19.2) | 6 (46.2) | 0.01 | 2 (10.5) | 0.37 | |
PC20 ⩽16 mg/ml† | ||||||
Non-work-related respiratory symptoms | 49 (16.4) | 4 (30.8) | 0.15 | 1 (5.3) | 0.17 | |
Non-work-related symptoms of RC | 101 (33.9) | 7 (53.9) | 0.12 | 4 (21.1) | 0.22 |
*p value in χ2 analysis comparing cases (with incident symptoms) with referents within the cohort; †n = 297 for methacholine bronchial challenge test.
BHR, bronchial hyper-responsiveness; PC20, provocative concentration causing a 20% decrease in forced expiratory volume in one second; RC, rhinoconjunctivitis.